Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease.

INTRODUCTION: Exacerbations are a leading cause of morbidity in COPD. The objective of this study was to identify metabolomic biomarkers of acute exacerbations of COPD (AECOPD). METHODS: We measured metabolites via mass spectrometry (MS) in plasma drawn within 24 hours of admission to the hospital for 33 patients with an AECOPD (day 0) and 30 days later and for 65 matched controls. Individual metabolites were measured via selective reaction monitoring with mass spectrometry. We used a mixed-effect model to compare metabolite levels in cases compared to controls and a paired t-test to test for differences between days 0 and 30 in the AECOPD group. RESULTS: We identified 377 analytes at a false discovery rate of 5% that differed between cases (day 0) and controls, and 31 analytes that differed in the AECOPD cases between day 0 and day 30 (false discovery rate: 5%). Tryptophan was decreased at day 0 of AECOPD compared to controls corresponding to an increase in indoleamine 2,3-dioxygenase activity. CONCLUSION: Patients with AECOPD have a unique metabolomic signature that includes a decrease in tryptophan levels consistent with an increase in indoleamine 2,3-dioxygenase activity.

Peptides in Bronchoalveolar Lavage in Chronic Obstructive Pulmonary Disease.

BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease with a significant public health burden. Currently there is no biomarker that identifies those at risk of developing COPD, progression of disease or disease phenotypes. We performed metabolomic profiling of bronchoalveolar lavage fluid (BALF) from COPD patients to determine if metabolites correlated with clinical measurements such as lung function, functional status and degree of emphysema. METHODS: Metabolomic components of BALF from 59 subjects with COPD and 20 healthy controls were separated by reversed-phase UPLC and analyzed by ESI-ToF mass spectrometry. We used univariate analysis and multiple regression models to investigate associations between metabolomic features and various clinical variables, such as lung function, functional status as measured by the St. George Respiratory Quotient Score and emphysema as measured by the CT density mask score. RESULTS: We identified over 3900 features by mass spectrometry, many consistent with peptides. Subjects with severe COPD had increased concentration of peptides compared to controls (p < 9.526e-05). The peptide concentration correlated with spirometry, specifically pulmonary function tests associated with airflow obstruction. There was no correlation with CT density, i.e. emphysema, or functional status. CONCLUSIONS: Metabolomic profiling of BALF in COPD patients demonstrated a significant increase in peptides compared to healthy controls that associated strongly to lung function, but not emphysema or functional status.

Effect of coating electrolytes on two-tailed surfactant bilayer coatings in capillary electrophoresis.

Surfactants such as dioctadecyldimethylammonium bromide (DODAB) form semi-permanent coatings that effectively prevent adsorption of cationic proteins onto the fused silica capillary in capillary electrophoresis (CE). The bilayer coating is generated by flushing the capillary with a 0.1 mM surfactant solution. However, formation of the bilayer is strongly dependent on the coating electrolyte. The effect of counter-ions, electrolyte concentrations and buffer co-ions were monitored based on: the separation of basic model proteins; the adsorption kinetics of DODA(+) onto fused silica; and dynamic light scattering (DLS) to determine vesicle size. Low concentrations (≤10.0 mM) and/or weakly associating buffers such as phosphate (pH 3.0), acetate (pH 4.0) and chloride should be used for DODAB coating solutions. Dissolving the surfactant in strongly associating electrolyte, such as phosphate at pH 7.0, results in poor coating of the capillary surface. Effective cationic bilayer coatings are formed if the buffer conditions favor formation of vesicles with diameters<300 nm. Monitoring turbidity at 400 nm provides a convenient means of verifying vesicle diameter variation of <5 nm; that is, that the coating solution is effective.

Surfactant bilayer coatings in narrow-bore capillaries in capillary electrophoresis.

The cationic surfactants didodecyldimethylammonium bromide (DDAB) and dioctadecyldimethyl-ammonium bromide (DODAB) have previously been shown to form semi-permanent coatings that effectively prevent adsorption of cationic proteins in fused silica capillaries with inner diameters of 25-75 µm. This paper investigates the impact that narrower capillary diameters (≤25 µm) have on the stability of surfactant bilayer coatings and the efficiency of separations of model cationic proteins and neurotransmitters. Using a DODAB-coated 5 µm i.d. capillary 210 consecutive protein separations (1050 min) were performed without recoating the capillary between runs. Separation efficiencies of 1,400,000-2,000,000 plates per m (340,000-430,000 plates) were obtained. Migration time reproducibilites of 6.8% RSD were observed for 300 injections performed over a 30 day period without any regeneration of the coating. Neurotransmitters were separated with efficiencies ranging from 470,000-610,000 plates per m (110,000-140,000 plates) in a 5 µm capillary.

Factors affecting the behavior and effectiveness of phospholipid bilayer coatings for capillary electrophoretic separations of basic proteins.

Phospholipid bilayer coatings can prevent adsorption of cationic proteins on the surface of fused silica capillaries used in capillary electrophoresis. However, the performance of such bilayer coatings is strongly dependent on solution conditions. The factors affecting the rate of formation of phospholipid bilayer coatings were investigated using the double-chained zwitterionic 1,2-dimyristoyl-sn-glycero-phosphocholine (DMPC, C(14)) as a model phospholipid. The effectiveness of these coatings for CE separations of model cationic lysozyme, cytochrome c, ribonuclease A, and alpha-chymotrypsinogen A was also assessed. Increasing the ionic strength of a 0.1 mM DMPC solution reduced capillary coat times from >2 hours in 2.5 mM Tris (pH 7.4) buffer to 3.4 min in 40 mM Tris and dramatically improved separation performance such that > or =1.4 x 10(5) plates/m were observed in capillaries coated for 5 min with 0.1 mM DMPC in 20 mM Tris-HCl (pH 7.4). The presence of Ca(2+) in the coating solution also increases the rate of formation of the phospholipid bilayer coating. The type of vesicle strongly affects its adsorption rate onto the silica surface. The time required to coat the capillary was 7.2 min for small unilamellar vesicles (SUVs) and 22.5 min for large unilamellar vesicles and excessively long for multilamellar vesicles. Highest efficiency protein separations were achieved with bilayer coatings prepared from SUVs. The coating rate was enhanced by using greater DMPC concentrations and unaffected by pH. The type of buffer present in the DMPC coating solution affects the coating behavior, with HEPES buffer yielding a faster coat time than either Tris or phosphate buffers. Histone H1 was separated on a 0.1 mM DMPC-coated capillary.

Non-covalent capillary coatings for protein separations in capillary electrophoresis.

Adsorption of proteins, particularly basic proteins onto fused silica capillaries severely degrades capillary electrophoretic performance. This review provides a synopsis of the fundamentals underlying protein adsorption and its impact on CE performance. The efficacy of small molecule background electrolyte additives, surfactants, physically adsorbed polymers (dynamic and static), and successive multiple ionic-polymer layer coatings are evaluated using a number of performance metrics. Peak efficiency and migration time reproducibility are used as measures of reversible protein adsorption, while protein recovery, electroosmotic flow reproducibility and step changes in the baseline are used as indicators of irreversible protein adsorption.